Our Labs
Beaudin Research Lab
Our primary research focus is to understand the contribution of fetal hematopoietic, or blood progenitors to adult immune function and disease susceptibility.
Bray Research Lab
The goals of Dr. Bray's lab are to understand better megakaryocyte growth and differentiation, and platelet production and function.
Buckley Research Lab
The goal of my lab is to utilize genomic and proteomic approaches in normal and malignant hematopoietic cells as well as mouse models to study molecular mechanisms regulating cell fate decisions.
Camp Research Lab
The Camp Lab The Camp research group focuses on the identification of inherited genetic mutations that increase risk to cancers, specifically breast cancer and hematological malignancies.
Christian Research Labs
The long term goal of our research program is to understand how members of the Transforming growth factor ß (TGFß), Bone morphogenetic (BMP) and Wnt families function in development and disease.
Dorrance Research Lab
We are focused on understanding the underlying mechanisms involving the process of leukemogenesis to identify novel targeted therapies.
Elf Research Lab
Our mission is to identify and characterize novel molecular vulnerabilities in myeloid blood cancers that can be targeted for the therapeutic intervention, with the long-term goal of improving upon current treatment regimens for these diseases.
Garzon Research Lab
Garzon’s research focuses on the molecular mechanisms of leukemia, particularly acute myeloid leukemia, to provide more effective treatments.
Leibold Research Lab
The Leibold Lab is interested in how eukaryotic cells sense and respond to iron and how dysregulation of iron metabolism leads to disease.
A Patel Research Lab
The A Patel Research Lab focuses on understanding cell signaling in myeloid leukemias and the molecular mechanisms governing drug resistance to targeted agents in these diseases. Her laboratory-based research complements her clinical practice by informing novel treatment strategies for implementation in early-phase clinical trials - with the goal of rapidly translating relevant preclinical findings and improving outcomes for leukemia patients.
Prchal Research Lab
The Prchal Lab focuses to elucidate the molecular basis of hematological diseases to discover their either somatic or germline underlying mutations and then determine the functions of the mutations.
Rondina Research Lab
Dr. Rondina's laboratory focuses on discovering how inflammation alters gene expression in platelets and their progenitor cells, megakaryocytes.
Rowley Research Lab
We seek to understand how platelets and megakaryocytes influence human health and disease. We merge clinical discovery with cutting edge molecular, cellular, in vivo, and computational approaches to define mechanisms of platelet function, and uncover new avenues for platelet diagnostics and therapeutics.
Shami Research Lab
The Shami lab focuses on the development of novel drugs for the treatment of acute myeloid leukemia (AML).
Song Research Lab
My current research focuses on the evolutionary adaptation of the Andean Aymara to high-altitude hypoxia. This includes the discovery of NFKB1 variants that have evolved selectively in the Aymara population and their association with high hemoglobin levels. I am also investigating the role of HIF and iron deficiency in thrombosis in MPNs to to identify novel therapeutic targets.
Winge Research Lab
The Winge Lab is focused on cellular mitochondria, particularly the biogenesis of the mitochondrial electron transfer respiratory complexes II, III and IV within this organelle.